23 May 2013
Keywords: scios, complete, natrecor, ph, iii, completed, phase
Article | 15 January 1998
Scios has completed a Phase III safety trial of Natrecor (humanb-type natriuretic peptide) in the treatment of acute congestive heart ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.